학술논문
TP-317, a first-in-class resolvin E1 small molecule, drives adjuvant efficacy in solid tumors by engaging innate and adaptive anti-tumor immunity in the tumor microenvironment (TME) and has neoadjuvant potential
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15388514